Business Context and Reporting Period
This Form 8-K Current Report was filed by Advance Auto Parts, Inc. on March 4, 2016, with the earliest event reported on the same date. The filing primarily addresses corporate governance changes regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial performance data.
Material Changes
The material change reported is the appointment of two new independent directors to the Board of Directors, effective March 7, 2016:
- Brad W. Buss: Appointed as an independent director and member of the Audit and Finance Committees. He previously served as CFO of SolarCity Corporation and holds board positions at Tesla Motors, Inc. and Café Press Inc.
- Reuben E. Slone: Appointed as an independent director and member of the Audit and Finance Committees. He previously served as Senior Vice President, Supply Chain Management at Walgreen Co.
Both directors will serve until the next annual meeting of stockholders or until their successors are elected. Their compensation will align with the company's existing practices for non-employee directors.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items. The document references a press release dated March 7, 2016, for further details on the appointments.
Investor Verification Checklist
- Verify the effective date of the new directors' service (March 7, 2016).
- Confirm the specific committee assignments (Audit and Finance) for Brad W. Buss and Reuben E. Slone.
- Review the Definitive Proxy Statement on Schedule 14A (filed April 6, 2015) to understand the compensation structure for non-employee directors.
- Check the referenced press release (Exhibit 99.1) for additional biographical details or strategic rationale for the appointments.